Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/30/24 19:33 | 1/26/24 | RNXT | Health | Drug | Pharmaceutical Preparations | Agah Ramtin | CA | DO | Chief Me | P.d | 0 | 0.00 | 0 | 41 | 633 | 47 | D | ||||||||||||||
1/30/24 19:00 | 1/26/24 | RNXT | Health | Drug | Pharmaceutical Preparations | Spiegel Robert J. | CA | D | P.d | 0 | 0.00 | 0 | 41 | New | 41 | D | |||||||||||||||
1/30/24 18:57 | 1/26/24 | RNXT | Health | Drug | Pharmaceutical Preparations | Bagai Shaun | CA | DO | CEO | P.d | 0 | 0.00 | 0 | 41 | 16 | 293 | D | ||||||||||||||
1/30/24 18:32 | 1/26/24 | RNXT | Health | Drug | Pharmaceutical Preparations | Marton Laurence | CA | D | P.d | 0 | 0.00 | 0 | 8 | 32 | 34 | D | |||||||||||||||
1/30/24 18:30 | 1/26/24 | RNXT | Health | Drug | Pharmaceutical Preparations | Macfarlane K. Angela | CA | D | P.d | 0 | 0.00 | 0 | 41 | New | 41 | D | |||||||||||||||
10/4/23 16:44 | 10/3/23 | RNXT | Health | Drug | Pharmaceutical Preparations | Nelms Angela | CA | O | COO | P | 1 | 1.05 | 0 | 1 | New | 1 | D | ||||||||||||||
6/9/22 06:04 | 6/7/22 | RNXT | Health | Drug | Pharmaceutical Preparations | Agah Ramtin | CA | DOT | Chief Me | P | 10 | 1.93 | 0 | 5 | 1 | 981 | M | ||||||||||||||
5/23/22 06:09 | 5/19/22 | RNXT | Health | Drug | Pharmaceutical Preparations | Bagai Shaun | CA | DO | CEO | P | 11 | 2.05 | 0 | 6 | 2 | 252 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |